GHRP-6 Research for Cardiac Protection
An evidence-based overview of research examining GHRP-6 in the context of cardiac protection. This page synthesizes findings from peer-reviewed literature.
Research Summary
Cuban CIGB research has extensively studied GHRP-6 for cardioprotection. Animal studies show reduced infarct size, preserved mitochondrial function, and protection against chemotherapy-induced cardiotoxicity. The 2024 stroke trial (Phase I/II) with EGF+GHRP-6 demonstrated safety but efficacy remains unproven in humans.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cardiac Protection
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. GHRP-6 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.